Clinical Trial Update: Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated once-daily ciprofloxacin extended-release 1000 mg for 7 to 14 days in adults with complicated urinary tract infections caused by Ps…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Urinary Tract Infection

Drugs mentioned

• Ciprofloxacin Extended-Release (Cipro XR) (ciprofloxacin)

Snippet

Sponsor: Bayer | Conditions: Urinary Tract Infections | Phase 4 | Status: COMPLETED